Clozapine treatment of psychosis associated with velo‐cardio‐facial syndrome: benefits and risks
Authors:
- 20 June 2005
- journal article
- case report
- Published by Wiley in Journal of Intellectual Disability Research
- Vol. 49 (7) , 567-570
Abstract
Background Clozapine is licensed for the treatment of psychotic illnesses resistant to other antipsychotic medications. Velo‐cardio‐facial syndrome (VCFS) is associated with a vulnerability to psychotic illness that may be resistant to treatment with conventional typical and atypical antipsychotics.Patients and methods A 32‐year‐old man with intellectual disability (ID) and a long history of treatment‐resistant psychosis was found to have VCFS. Treatment with typical antipsychotic drugs and with one atypical olanzapine produced no improvement.Results Treatment with clozapine produced an improvement in psychotic symptoms and associated behavioural abnormalities, but caused hypersalivation, constipation and a seizure disorder. The latter led to two fractures, one requiring surgery. The addition of sodium valproate stopped seizures.Conclusions Clozapine may improve psychotic symptoms for people with ID associated with VCFS, but clinicians should be alert for potential adverse effects.Keywords
This publication has 14 references indexed in Scilit:
- Two cases of generalized seizures and the Velocardiofacial syndrome - a clinically significant association?Journal of Intellectual Disability Research, 2004
- The behavioural phenotype in velo‐cardio‐facial syndromeJournal of Intellectual Disability Research, 2004
- The use of clozapine in adults with intellectual disabilityJournal of Intellectual Disability Research, 2004
- 22q11 deletion syndrome in childhood onset schizophrenia: an updateMolecular Psychiatry, 2003
- The Schizophrenia Phenotype in 22q11 Deletion SyndromeAmerican Journal of Psychiatry, 2003
- Use of clozapine in a mental handicap hospital — report of the first 17 patientsIrish Journal of Psychological Medicine, 1997
- Bipolar spectrum disorders in patients diagnosed with velo-cardio- facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?American Journal of Psychiatry, 1996
- Psychotic Illness in Patients Diagnosed with Velo-Cardio-Facial Syndrome and Their RelativesJournal of Nervous & Mental Disease, 1994
- Velo‐cardio‐facial syndrome: A review of 120 patientsAmerican Journal of Medical Genetics, 1993
- Late‐Onset psychosis in the velo‐cardio‐facial syndromeAmerican Journal of Medical Genetics, 1992